Media

BIO Investor Forum to be held October 7-8, 2014 in San Francisco, California
Survey responses will help inform Prescription Drug User Fee Act VI negotiations

Press Releases

Mar 3 1999
Washington, D.C. (March 3, 1999) --- The Biotechnology Industry Organization (BIO) said today it will support Pioneer HiBred International Inc. in efforts to...
Feb 24 1999
NEW YORK, N.Y., (February 24, 1999) -- Twenty-one new biotechnology drugs, vaccines and new indications for existing drugs were approved by the Food and Drug...
Feb 19 1999
  Libby Mikesell, Director of Communications at the Biotechnology Industry Organization (BIO), issued the following statement in response to reports...
Feb 11 1999
  Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement on the legislation introduced Wednesday...
Feb 8 1999
WASHINGTON, D.C. (Feb. 8, 1999) Among the investor sessions featured at the Biotechnology Industry Organization's (BIO) annual CEO & Investor...
Jan 19 1999
WASHINGTON, D.C. (Jan. 19, 1999) Fifty-two companies will participate in the annual CEO & Investor Conference organized by the Biotechnology Industry...
Jan 15 1999
BIO has long been concerned about the possible misuse of genetic or medical information. Recent news reports about plans to collect data on the health...
Jan 15 1999
The Biotechnology Industry Organization issued the following statement from its Executive Director, Technical Affairs, Alan Goldhammer, Ph.D.: "Health...
Nov 12 1998
(WASHINGTON, D.C., November 12, 1998). . . Carl B Feldbaum, president of the Biotechnology Industry Organization (BIO), today issued the following statement...


Biotechnology News

September 2, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (Nasdaq: BLUE) announces that management will present at the Morgan Stanley Global Healthcare Conference on Wednesday...

September 2, 2014

AUDUBON, Pa.--(BUSINESS WIRE)--Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced that Richard Baron, Senior Vice President...

September 2, 2014

CINCINNATI--(BUSINESS WIRE)--Aerpio Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases, today...

September 2, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced today the appointment of Thomas Graney as chief financial officer (CFO) and...

September 2, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with...